Board Meeting Details

  • Meeting Date: Thursday, August 13, 2026
  • Purpose: To consider and approve two key agenda items

Agenda Item 1: Financial Results

Consideration and approval of the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2026.

Agenda Item 2: Fundraising Proposal

Consideration and evaluation of proposal for raising funds through issuance of one or more instruments/securities including:

  • Equity shares
  • Fully convertible warrants
  • Any other eligible securities (convertible/non-convertible)
  • Any combinations of securities

Fundraising Methods

Through permissible modes including but not limited to:

  • Preferential issue on a private placement basis
  • Any other permissible mode
  • Combination thereof as considered appropriate

Regulatory Framework

Fundraising to be conducted in accordance with:

  • Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018
  • Companies Act, 2013, as amended

Potential Allottees

Funds may be raised to the promoter/promoter group.

Approvals Required

Subject to all such approvals as may be required including:

  • Shareholders' approval
  • Regulatory/statutory approvals
  • Other applicable approvals

Trading Window Closure

Pursuant to the Company's Code of Conduct for Prevention of Insider Trading:

  • Trading Window for dealing in the Company's securities remains closed
  • Closure period: Until August 15, 2026 (both days inclusive)

Additional Disclosure

This intimation is being uploaded on the Company's website at https://krsnaadiagnostics.com/investors/